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Abstract
The main reason for recreational use of cannabis is the 'high', the primary psychotropic effect of Δ9-
tetrahydrocannabinol (THC). This psychoactive compound of cannabis induces a range of subjective,
physical and mental reactions. The effect on heart rate is pronounced and complicates bloodflow-based
neuroimaging of psychotropic effects of THC. In this study we investigated the effects of THC on baseline
brain perfusion and activity in association with the induction of 'feeling high'. Twenty-three subjects
participated in a pharmacological MRI study, where we applied arterial spin labelling (ASL) to measure
perfusion, and resting-state functional MRI to assess blood oxygen level-dependent signal fluctuation as a
measure of baseline brain activity. Feeling high was assessed with a visual analogue scale and was compared to
the imaging measures. THC increased perfusion in the anterior cingulate cortex, superior frontal cortex, and
insula, and reduced perfusion in the post-central and occipital gyrus. Baseline brain activity was altered,
indicated by increased amplitude of fluctuations in resting-state functional MRI signal after THC
administration in the insula, substantia nigra and cerebellum. Perfusion changes in frontal cortex were
negatively correlated with ratings of feeling high, suggesting an interaction between cognitive control and
subjective effects of THC. In conclusion, an acute THC challenge altered baseline brain perfusion and
activity, especially in frontal brain areas involved in cognitive and emotional processes, and the insula,
associated with interoceptive awareness. These changes may represent the THC-induced neurophysiological
correlates of feeling high. The alterations in baseline brain perfusion and activity also have relevance for
studies on task-related effects of THC on brain function.
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Abstract
The main reason for recreational use of cannabis is the ‘high’, the primary psychotropic effect of
D9-tetrahydrocannabinol (THC). This psychoactive compound of cannabis induces a range of subjective,
physical and mental reactions. The effect on heart rate is pronounced and complicates bloodflow-based
neuroimaging of psychotropic effects of THC. In this study we investigated the effects of THC on baseline
brain perfusion and activity in association with the induction of ‘feeling high’. Twenty-three subjects
participated in a pharmacological MRI study, where we applied arterial spin labelling (ASL) to measure
perfusion, and resting-state functional MRI to assess blood oxygen level-dependent signal fluctuation as
a measure of baseline brain activity. Feeling high was assessed with a visual analogue scale and was
compared to the imaging measures. THC increased perfusion in the anterior cingulate cortex, superior
frontal cortex, and insula, and reduced perfusion in the post-central and occipital gyrus. Baseline brain
activity was altered, indicated by increased amplitude of fluctuations in resting-state functional MRI
signal after THC administration in the insula, substantia nigra and cerebellum. Perfusion changes in
frontal cortex were negatively correlated with ratings of feeling high, suggesting an interaction between
cognitive control and subjective effects of THC. In conclusion, an acute THC challenge altered baseline
brain perfusion and activity, especially in frontal brain areas involved in cognitive and emotional
processes, and the insula, associated with interoceptive awareness. These changes may represent the
THC-induced neurophysiological correlates of feeling high. The alterations in baseline brain perfusion
and activity also have relevance for studies on task-related effects of THC on brain function.
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Introduction
Cannabis is one of the most widely used drugs in
the world. Its main psychoactive constituent,
D9-tetrahydrocannabinol (THC), produces a number
of acute, dose-dependent psychotropic effects, such as
‘feeling high’, relaxation and euphoria which are re-
garded as the main reason why people use cannabis
(Green et al. 2003). In addition, feeling high has been
reported as the most stable subjective effect of THC or
cannabis administration, as recently reviewed by
Zuurman et al. (2009). Effects on cognition are also
frequently reported, such as memory impairments
(Bhattacharyya et al. 2009; Grotenhermen, 2002).
In addition to these, THC has prominent effects on
blood pressure and heart rate, and causes cerebral
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vasodilatation (Wagner et al. 2001). All of these effects
can be expected to reflect changes in brain function
and perfusion. Brain-imaging studies have measured
acute effects of cannabis (THC) on baseline brain per-
fusion in humans, using positron emission tomogra-
phy (PET) (Chang & Chronicle, 2007; Martin-Santos
et al. 2010), the main outcome of which is that THC
administration increases regional cerebral blood flow
(rCBF) in prefrontal, insular, and anterior cingulate
regions. Changes in rCBF have been associated with
many aspects of THC-induced behavioural effects
such as a changed time perception, increased anxiety,
intoxication levels and arousal (Mathew & Wilson,
1993 ; Mathew et al. 1989, 1992, 1997, 1998, 1999, 2002).
Yet, the specific neurophysiological correlate of the
main reason for recreational use of THC, the feeling
high, remains to be elucidated.
Recent advances in magnetic resonance imaging
(MRI) techniques have provided the arterial spin
labelling (ASL) technique, which offers a quantitative
and non-invasive measure of CBF (Petersen et al.
2006). ASL employs blood as an endogenous tracer by
magnetically labelling arterial blood water (Detre &
Alsop, 1999 ; Williams et al. 1992). This technique can
be administered repeatedly within a scan session,
making it very attractive for studies involving a phar-
macological challenge (Liu & Brown, 2007).
Perfusion, however, does not immediately reflect
brain activity when a drug is administered with
potential effects on cerebrovasculature, such as
THC. An additional measure of brain activity would
thus be informative for assessing effects of THC on
baseline brain function, the most obvious being
functional MRI (fMRI). Both techniques can be ap-
plied within the same scan session, allowing for a
rich assessment of effects of a pharmacological chal-
lenge. Moreover, it constitutes an advancement in
study design compared to the previously mentioned
PET studies (Mathew & Wilson, 1993 ; Mathew et al.
1989, 1992, 1997, 1998, 1999, 2002) because it allows
for a combination of within-subject placebo–drug
comparisons (multiple sessions) without exposing
subjects to radioactivity twice, with pre- and post-
administration measurements for corrections of
baseline values, thereby improving internal validity
of the data.
Blood oxygen level-dependent (BOLD) fMRI is
currently the preferred technique for studying the
acute effects of THC on specific brain functions.
fMRI studies have reported THC-induced alterations
in brain activity during emotional, inhibitory,
and memory processes (Bhattacharyya et al. 2009;
Borgwardt et al. 2008; Fusar-Poli et al. 2009). These
pharmacological imaging studies used task-
dependent fMRI, i.e. fMRI in combination with a cog-
nitive challenge. So far, these have not addressed the
effects that THC may have on baseline brain activity
during rest. Here we present a pharmacological MRI
(phMRI) study aimed at bridging this knowledge
gap by investigating the acute psychotropic effects of
THC on brain neurophysiology. We combined a ran-
domized, double-blind, placebo-controlled design
with ASL and resting-state fMRI techniques to assess
the intrinsic effects of THC administration on global
and regional perfusion and on BOLD signal fluctu-
ation as a measure of baseline brain activity. Ad-
ditionally, subjective effects of THC were measured
with visual analogue scales (VAS), and heart rate
and respiration were continuously monitored. We ex-
pected that THC administration, in line with findings
from PET studies, would increase brain perfusion in a
region-specific manner, predominantly in frontal and
limbic areas.
For analysis of the resting-state data we chose to
apply a robust measure of signal fluctuations, and not
to rely on assumptions in terms of specific fluctuation
frequencies [amplitude of low-frequency fluctuations
(ALFF) ; Zou et al. 2008] or in terms of specific net-
works [independent component analysis (ICA);
Damoiseaux et al. 2006]. A reliable measure of fluctu-
ation amplitude of the BOLD signal over time is the
temporal signal-to-noise ratio (tSNR), computed by
dividing the mean BOLD signal over a period of time
by its standard deviation. The tSNR is first computed
per voxel, and then averaged across all voxels in the
brain. Given the fact that the distribution of power
across frequencies in fMRI follows a 1/frequency re-
lationship (Zarahn et al. 1997), the tSNR is dominated
by lower frequencies. Hence, a high tSNR corresponds
largely to low ALFF and vice versa. As the tSNR is
affected by all frequencies, it reflects all physiological
fluctuations (Zou et al. 2008). Given that an increase in
brain activity is accompanied by increased spon-
taneous signal fluctuations (Yang et al. 2007), we hy-
pothesized that the psychotropic effects of THC would
be reflected by reduced tSNR in the involved regions.
Materials and methods
This study is part of the Pharmacological Imaging
of the Cannabinoid System (PhICS) study, a com-
prehensive research project on the role of the endo-
cannabinoid system in the regulation of cognitive
brain function in healthy volunteers and patients with
psychiatric disorders. Methods and study protocol are
reported in detail in a methodological paper (van Hell
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et al. 2011). Here we focus on ASL and resting-state
fMRI measurements.
Subjects
Twenty-six male subjects were scanned at the
University Medical Centre Utrecht after the inhalation
of either placebo or THC, on two separate study days.
Inclusion and exclusion criteria are described by van
Hell et al. (2011), the most important being that sub-
jects needed to be occasional cannabis users (i.e. use at
least four times a year but at most once a week) who
never had negative experiences after cannabis use (e.g.
bad trip, cannabis-induced psychosis). Subjects were
excluded if they or their first-degree relatives had been
diagnosed with a psychiatric disorder according to
DSM-IV criteria. All volunteers gave written informed
consent before entry into the study and were paid
E250 for participation. For the progress of subjects in
the study, see the CONSORT diagram (Fig. 1). The
study was approved by the Ethical Committee of the
University Medical Centre Utrecht in accordance with
the Declaration of Helsinki 2008.
Procedure
At a practice session, subjects completed personality
questionnaires and performed the Dutch Adult
Reading Test (DART) which estimates verbal intelli-
gence. Subsequently, the procedure of drug adminis-
tration (inhalation) was practised and participants
were familiarized with the scan protocol in a mock
scanner to reduce stress effects on the following test
days. The actual study consisted of two test days,
separated by at least 2 wk to allow for complete
clearance of drugs. Subjects were instructed not to use
cannabis from 2 wk before the first test day until study
completion. Clearance of drugs was tested by means
of a urine sample at the beginning of each test day.
Additionally, no alcohol was permitted in the 48 h
preceding a test day, and subjects needed to refrain
from smoking, eating and drinking during the 4 h
preceding a test session. A standard breakfast or lunch
was provided at the beginning of each test day, to
ensure equal states of metabolism on both test days.
A catheter was placed in the arm for venous blood
sampling.
Enrolment
Assessed for eligibility (n = 26)
Randomized (n = 26)
Excluded (n = 0)
• Not meeting inclusion criteria (n = 0) 
• Declined to participate (n = 0)
• Other reasons (n = 0)
Allocated to intervention placebo (n = 23) 
• Received allocated intervention (n = 23)
• Did not receive allocated intervention (give reasons) (n = 0)
Allocated to intervention THC (n = 23)
• Received allocated intervention (n = 23) 
• Did not receive allocated intervention (give reasons) (n = 0)
Lost to follow-up (give reasons) (n = 0)
Discontinued intervention (give reasons) (n = 3 – subjects
showed anxiety during scanning)
Lost to follow-up (give reasons) (n = 0)
Discontinued intervention (give reasons) (n = 0)
Analysed (n = 20)
• Excluded from analysis (give reasons) (n = 3 – data loss
 due to technical difficulties
Analysed (n = 20)
•  Excluded from analysis (give reasons) (n = 3 – data loss
  due to technical difficulties)
Follow-Up
Analysis
Allocation
Fig. 1. CONSORT flow diagram illustrating the progress of all subjects in the study. Twenty-six patients were included, three
subjects did not finish the study procedures due to feelings of anxiety during scanning, and for both arterial spin labelling and
resting-state, data of three subjects were lost due to technical difficulties.
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On test days subjects received THC or placebo by
means of a Volcano1 vaporizer (Zuurman et al. 2008)
at several time-points. Vehicle (ethanol only) was used
as a placebo. The first dose consisted of 6 mg THC
or placebo. To maintain equal levels of intoxicating
effects throughout the experiment, upload dosages of
1 mg were used, 30 min apart. Two ASL scans were
performed, one before and one after the first adminis-
tration of THC or placebo. Resting-state fMRI was
measured after the second or third upload dose of
THC or placebo [see Supplementary Fig. S1 (available
online), and van Hell et al. 2011].
Venous blood samples were collected to determine
plasma concentrations of THC and its two most
important metabolites, 11-OH-THC and 11-nor-9-
carboxy-THC. Blood samples were processed accord-
ing to Zuurman et al. (2008). Subjective effects were
measured before and after each task and throughout
the test day using self-reported VAS (Bond & Lader,
1974 ; Bowdle et al. 1998; Zuurman et al. 2008).
Psychedelic effects were assessed using an adapted
version of a 13-item VAS, originally described by
Bowdle et al. (1998). The VAS item ‘Feeling high’
(defined as the specific psychological effects experi-
enced after THC or cannabis intake) was analysed
individually and composite scores of ‘External per-
ception’ (comprising of six VAS subscores) and ‘In-
ternal Perception’ (comprising of five VAS subscores)
were calculated (see Zuurman et al. 2008). Changes in
external perception reflect a misperception of an ex-
ternal stimulus or a change in the awareness of the
subject’s surroundings. Internal perception reflects
inner feelings that do not correspond with reality
(Zuurman et al. 2008). Furthermore, heart rate and
respiratory function were monitored continuously
during scanning. Heart rate was assessed by measur-
ing the electrocardiogram using four electrodes at-
tached to the subject’s chest, and respiratory function
was assessed by measuring the expansion of a respir-
ation band around the subject’s abdomen. The cardiac
and respiratory signals were sampled at a frequency of
500 and 100 Hz, respectively.
Scanning parameters
Image acquisition was performed on a Philips
Achieva 3.0-T MR scanner with a Quasar dual gradi-
ent set (Philips Medical Systems, The Netherlands).
ASL
Pseudo-continuous labelling was performed by
employing a train of radio-frequency (RF) pulses
(duration 0.5 ms) with an interpulse pause of 0.5 ms in
combination with a balanced gradient scheme (Dai
et al. 2008; Wu et al. 2007). The duration of labelling
was 1650 ms. The control situation was achieved by
adding 180x to the phase of every other RF pulse. ASL
imaging was performed in combination with back-
ground suppression, which consisted of a saturation
pulse immediately before labelling and inversion
pulses at 1680 ms and 2830 ms after the saturation
pulse. Imaging was performed with single-shot echo
planar imaging (EPI) in combination with parallel
imaging (SENSE factor 2.5). In total, 17 slices of 7-mm
thickness were acquired in ascending fashion with an
in-plane resolution of 3r3 mm2. Imaging was per-
formed 1525 ms after labelling stopped. The total scan
time for a pair of control and label images was 8 s. For
measurement of the magnetization of arterial blood
(M0) and also for segmentation purposes, an inversion
recovery sequence was acquired with the same ge-
ometry and resolution as the ASL sequence (inversion
times : 100–1900 ms with 200 ms intervals, preceded
by a saturation pulse at x1680 ms) (van Osch et al.
2009).
Resting-state fMRI
For the BOLD resting-state scan, a single run of 400
volumes was obtained over a period of 4 min using a
SENSE-PRESTO scan protocol (Neggers et al. 2008)
(scan parameters : TR 22.5 ms, TE 33.2 ms, flip
angle=10x, FOV 224r256r160, matrix 56r64r40,
voxel size 4.0 mm isotropic, acquisition time per vol-
ume 0.6075 s, 40 slices, sagittal orientation). A high-
contrast volume with a flip angle of 27x (FA27) was
scanned for registration purposes. Before the func-
tional imaging run, a high-resolution whole-brain
anatomical scan was performed (scan parameters : TR
9.4 ms, TE 4.7 ms, flip angle=8x, FOV 220.8r240r
159.6, matrix 368r400r113, voxel size 0.6r0.6r
0.6 mm, 266 slices, sagittal orientation).
During the ASL scans as well as the BOLD fMRI
resting-state scan, subjects were instructed to lie still
and keep their eyes open.
Analysis
Behavioural and physiological measures
VAS feeling high scores were corrected for baseline
values and analysed using repeated-measures
ANOVA with drug and time as within-subject factors
(Zuurman et al. 2008). Mean heart rate was calculated
for every scan (i.e. ASL before administration, ASL
after administration, and BOLD fMRI resting-state, for
placebo and THC sessions separately).
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ASL
ASL perfusion images were motion-corrected in SPM5
(Wellcome Trust Centre for Neuroimaging, London,
UK) prior to subtraction of control images from per-
fusion-weighted images. The subtraction images were
subsequently averaged. Quantitative CBF maps were
calculated in ml/100 ml per min from the ASL images
using a formula described by van Osch et al. (2009).
CBF maps were realigned, normalized, and spa-
tially smoothed (FWHM=8 mm) in SPM5. Global CBF
was calculated for every individual separately, by
averaging CBF values in the whole brain excluding
cerebrospinal fluid. Individual CBF maps were nor-
malized for global CBF. Group results were analysed
using paired-sample t tests in SPM5 (placebo vs. THC).
Resting-state fMRI
fMRI preprocessing. Resting-state data were pre-
processed and analysed using SPM5. Preprocessing
of data included realignment of functional images
and co-registration with the anatomical scan using the
FA27 volume. Subsequently, functional scans were
normalized into standard MNI space and smoothed
(FWHM=8 mm).
Before statistical analyses, the BOLD signal was
corrected for cardiac and respiratory measures using
the RETROICOR method (for details see Glover et al.
2000). Cardiac and respiratory phases were calculated
per image. A trigger marked peaks in the cardiac sig-
nal. Cardiac phase was assumed to advance linearly
from 0 to 2p during each peak-to-peak interval and
was reset to 0 for the next cycle. For the respiratory
phase, both time and amplitude of respiration were
accounted for. While inhaling, the phase advanced
from 0 to p, and during expiration the phase was ne-
gated. A transfer function was used to relate the am-
plitude of respiration to the phase of respiration
(see Glover et al. 2000). For each functional image, the
cardiac and respiratory phases were calculated.
RETROICOR then modelled the relationship between
the cardiac and respiratory phases and the BOLD sig-
nal, and corrected the BOLD signal accordingly. All
further analyses were done on these corrected data.
Temporal signal-to-noise
To assess fluctuations in the resting-state BOLD signal,
the tSNR was calculated per voxel by dividing
the mean signal of the time-series (400 BOLD fMRI
resting-state scans) by the standard deviation
(see Supplementary online material for an in-depth
explanation of the use of tSNR). For further analysis
the tSNR was averaged across all voxels. For com-
parison between THC and placebo, tSNR values were
compared with a paired-sample t test in SPM5.
Multiple regression
Multiple regression analysis was used to determine
the relationship between imaging data and (psycho)-
physiology (heart rate and subjective measures of
feeling high). Regions of interest were defined based
on a group comparison of THC and placebo maps for
the ASL and BOLD data separately, selecting those
regions that showed significant differences in per-
fusion (T>3.6, p<0.001 uncorrected) or resting-state
BOLD signal (T>3.0, p<0.005 uncorrected) between
THC and placebo conditions. For those regions, dif-
ference scores were calculated by subtracting placebo
data from THC data.
For the ASL, both heart rate and feeling high scores
were used as regression factors, to assess the amount
of variance explained. For the BOLD resting-state data,
only feeling high scores were used as regression factor,
as effects of heart rate had been filtered out during
preprocessing (i.e. RETROICOR method).
Results
Demographic characteristics are presented in Table 1.
Three subjects did not complete both sessions due to
anxiety during scanning and were excluded from the
study. Subjects were on average aged 21¡2.2 (S.D.) yr
and had an IQ of 106¡5.2. Cannabis was used on av-
erage on 19¡11.2 occasions per year (median 17.5,
range 4–52). Subjects smoked on average 3.7¡8.4
cigarettes per week (median 0, range 0–30) and
16.3¡10.2 units of alcohol were consumed per week
(median 14.5, range 2–40). Hard drugs were used on
2.3¡3.4 occasions lifetime (median 1.0, range 0–15),
and last use was >6 months prior to participation in
the study.
Table 1. Demographic characteristics and patterns of
drug use
Characteristics Mean¡S.D. Range
Age (yr) 21.1¡2.1 18–27
IQ 105.7¡5.2 94–113
Nicotine use last year (cigarettes/wk) 3.7¡8.4 0–30
Alcohol use last year (units/wk) 16.3¡10.2 2–40
Cannabis use last year (no. occasions) 19.0¡11.2 4–52
Hard-drug use lifetime (no. occasions) 2.3¡3.4 0–15
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Physiological and subjective measures are pres-
ented in Table 2. THC plasma concentration reached a
maximum of 85.3¡52.8 ng/ml 4 min after inhalation
of 6 mg THC and decreased rapidly thereafter. Heart
rate significantly increased after THC administration
compared to placebo (p<0.001) during the post-
administration ASL scan. No significant difference in
heart rate was found between THC and placebo dur-
ing the BOLD resting-state scan. Subjective measures
of feeling high were significantly increased after THC
administration compared to placebo, after both the
post-administration ASL scan and the BOLD resting-
state scan (p<0.01).
A correlation analysis showed that peak THC plas-
ma concentration (at t=4 min) correlated significantly
with peak feeling high after THC (at t=27 min,
r=0.50, p<0.05), external perception (r=0.47, p<0.05)
and internal perception (r=0.52, p<0.05).
ASL
For three subjects one or more of the pre- or post-
administration ASL scans were lost due to technical
malfunction of the scanner. Twenty subjects com-
pleted the pre- and post-administration ASL scans
on both test days and were included in the analyses.
For each session pre-administration scans were
subtracted from post-administration scans to obtain
difference images. A paired-sample t test on the dif-
ference images (see Fig. 2) revealed that THC in-
creased perfusion compared to placebo in the anterior
cingulate cortex, the left superior frontal cortex,
and in the left and right insula (T>3.6, p<0.001
uncorrected, cluster size >10 voxels ; see Table 3).
THC showed significantly decreased perfusion com-
pared to placebo in the right post-central gyrus, as
well as in the left and right occipital gyrus (T>3.6,
p<0.001 uncorrected, cluster size >10 voxels ; see
Table 3).
Effects of feeling high and heart rate (both com-
puted as the baseline-corrected values for THC minus
placebo) in the regions showing a difference between
THC and placebo were assessed by means of re-
gression analysis. Multiple regression analysis
showed that the regression model containing these
two factors explained a significant part of the variance
in perfusion changes (THC vs. placebo) in left superior
frontal cortex (r2=0.48, p=0.01) and the anterior
cingulate cortex (r2=0.35, p=0.04). In the right oc-
cipital gyrus this effect was near-significant (r2=0.31,
p=0.07). To further break down effects of heart rate
and feeling high, regression analyses were performed
with either as dependent variable, and all seven
regions as independent variables. No effects were ob-
served for heart rate on model fit or separate re-
gressors (regions). Feeling high was significantly
explained (model fit p=0.005) and this was mainly
due to the left superior frontal cortex (b=x0.70,
p=0.002), and to some extent the left insula (b=0.42,
p=0.045). Thus, feeling high was correlated strongly
negative with superior frontal cortex, and moderately
positive with left anterior insula. Finally, regions were
compared directly to one another, revealing only a
positive correlation between the anterior cingulate and
the right insula (r=0.704, p=0.001).
Resting-state fMRI
For three subjects one of the resting-state scans was
lost due to technical problems. Twenty subjects com-
pleted the resting-state scan on both test days and
were included in the analysis.
Table 2. Physiological and behavioural effects of placebo and THC
Placebo THC p
Peak plasma concentration THC (ng/ml) – 84.1¡52.6 n.a.
Heart rate (bpm)
ASL pre-administration 67.6¡14.5 69.2¡10.3 n.s.
ASL post-administration 67.3¡9.8 84.3¡23.7 <0.001
BOLD 70.6¡20.8 78.0¡20.5 n.s.
Feeling High
ASL pre-administration 0 0 n.a.
ASL post-administration 2.9¡10.3 30.3¡29.7 <0.01
BOLD 2.1¡8.6 24.9¡29.2 <0.01
ASL, arterial spin labelling ; BOLD, blood oxygen level-dependent ; bpm, beats per
minute ; n.s., non-significant ; n.a., not applicable.
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Signal fluctuations in the BOLD resting-state data
were assessed by comparing the tSNR images between
THC and placebo with a paired-sample t test
(see Fig. 3). THC reduced tSNR in the right insula,
the left cerebellum, and the left substantia nigra
(T>3.0, p<0.005 uncorrected, cluster size>10 voxels ;
Table 3. Areas in which THC and placebo show significant differences in perfusion
(T>3.6, p<0.001 uncorrected, cluster size >10 voxels)
Area
Cluster size
(no. of
voxels)
Peak
t value
p value
cluster level
(uncorrected)
Location of t value
x y z
THC>placebo
Anterior cingulate cortex 16 6.31 0.007 x3 42 28
Superior frontal cortex L 12 5.56 0.017 x33 63 0
Insula L 59 4.92 0.000 x51 21 7
Insula R 16 4.24 0.009 30 24 x7
Placebo>THC
Post-central gyrus R 11 5.63 0.021 63 x3 21
Occipital gyrus R 50 5.97 0.000 42 x78 0
Occipital gyrus L 12 5.30 0.017 x36 x87 0
Arterial spin labelling
(a)
(b)
x = –33 y = 24
Anterior cingulate
L
z = –3
R
Insula
Insula
T = 0
Anterior cingulate
T = –3
T = –5 T = –3.6 T = 3.6 T = 5
y = 24x = –33 z = –3
T = 3Superior frontalOccipital gyrus
Superior frontalOccipital gyrus
Fig. 2. Arterial-spin-labelling difference maps between THC and placebo sessions. Red/yellow indicates areas showing
increased perfusion during THC compared to placebo, and blue/green indicates areas showing increased perfusion during
placebo compared to THC. (a) Overall differences between THC and placebo. (b) Areas that are significantly different between
THC and placebo (T>3.6, p<0.001 uncorrected, cluster size >10 voxels). L, Left ; R, right.
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see Table 4) compared to placebo. No areas showed
significantly higher tSNR after THC administration
compared to placebo. This indicates that BOLD fMRI
signal fluctuations increased after THC adminis-
tration. Multiple regression analysis showed no sig-
nificant correlation between THC effects on tSNR
and feeling high scores. Comparing THC effects in the
ASL and the tSNR regions, only a trend for a negative
correlation was found in the insula (ASL insula vs.
tSNR right insula, r=x0.45, p=0.06). Further, tSNR
values were assessed in the regions where ASL
showed differences between THC and placebo. In
these regions, tSNR values were similar for THC and
placebo.
Table 4. Areas in which THC and placebo show significant differences in temporal
signal-to-noise ratio (T>3.0, p<0.005 uncorrected, cluster size >10 voxels)
Area
Cluster size
(no.
of voxels)
Peak
t value
p value
cluster level
(uncorrected)
Location of t value
x y z
Placebo>THC
Substantia nigra L 16 5.72 0.022 x12 x12 x12
Insula R 19 4.59 0.014 40 16 x4
Cerebellum L 15 3.78 0.026 x12 x44 x32
Temporal signal-to-noise ratio
(a)
(b) Insula
Insula L R
z = 2y = 16
T = –3 T = 0 T = 3Substantia nigraCerebellum
x = –12 y = 16
T = –5 T = –3 T = 3 T = 5Cerebellum Substantia nigra
z = 2
x = –12
Fig. 3. Fluctuations in the fMRI BOLD signal ; difference maps of signal-to-noise ratio (tSNR) between THC and placebo sessions.
Red/yellow indicates areas showing higher tSNR during THC than during placebo, and blue/green indicates areas showing
higher tSNR during placebo than during THC. (a) Overall differences between THC and placebo. (b) Areas that are significantly
different between THC and placebo (T>3, p<0.005 uncorrected, cluster size >10 voxels). L, Left ; R, right.
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Discussion
This study investigated the acute effects of THC
on resting-state brain perfusion and activity, mea-
sured with ASL and BOLD fMRI, respectively, in
association with the psychotropic effect (feeling
high). Compared to placebo, THC increased perfusion
in the anterior cingulate cortex, the superior frontal
cortex, and the insula, whereas perfusion was de-
creased in the post-central gyrus and the occipital
gyrus. The feeling high effect of THC was negatively
correlated with changes in perfusion in the left
superior frontal cortex. THC increased fluctuation
of the resting-state BOLD signal in the insula,
the substantia nigra and the cerebellum, reflecting
increased baseline activity.
Effects of THC were observed on both perfusion
and on resting-state signal fluctuation in one specific
region, the right anterior insula. This is a structure in-
tegrating visceral, autonomic and hedonic information
(Uddin & Menon, 2009), which is represented in its
interconnections with the amygdala, hypothalamus,
anterior cingulate cortex and orbitofrontal cortex
(Craig, 2009a). The insula is implicated in many cog-
nitive brain functions, such as emotion, attention,
and motivation, and has recently been shown to play
an important role in addiction (Naqvi & Bechara,
2009). Insular activity is associated with interoceptive
awareness, a conscious representation of self
(Critchley et al. 2004) and self-reflection (Modinos et al.
2009), essential for generating a mental image of one’s
physical state (Craig, 2002). Moreover, the insula is
regarded as the primary sensory cortex for inner body
feelings like hunger and thirst, autonomic processes
and awareness thereof (Craig, 2008). A recent report
on epileptic seizures originating in the insula in-
dicated that this brain region plays an important role
in emotion and bodily feelings in relation to subjective
awareness. It was observed that increased insular ac-
tivity due to epileptic activity was associated with
feelings of intense wellbeing (Picard & Craig, 2009).
Hence, our finding of increased perfusion and elev-
ated signal fluctuation in the insula after THC admin-
istration could signify an increase in interoceptive
awareness, as well as an increase in wellbeing and/or
euphoria. The moderate correlation between feeling
high and perfusion in (left) anterior insula supports
this notion. Interestingly, perfusion was decreased by
THC in somatosensory cortex, and in visual cortex
which has been reported before (O’Leary et al. 2007). It
is not directly clear how this related to the psycho-
tropic effects of THC, but it is tempting to associate it
with the typically reported altered sensory perception
(Green et al. 2003). However, this needs further inves-
tigation.
The anterior cingulate cortex, associated with
various functions including attentional processes and
emotional control (Bush et al. 2000; Critchley, 2005),
evidenced elevated perfusion after THC adminis-
tration which was correlated with that in right insula.
These two regions are highly interconnected and are
often activated together during emotional processing
or bodily awareness (Craig, 2002, 2009b). Taylor et al.
(2009) showed strong resting-state functional connec-
tivity between these regions and proposed that this
may reflect integration of interoceptive information
with emotional salience to form a subjective image of
the bodily state. Craig (2009a, b) proposed a model
stating that the (anterior) insula is more implicated in
the sensory aspects of emotional processing, while the
anterior cingulate cortex is part of the motor limbic
cortices that constitutes motivation and initiates be-
haviour. Given that acute effects of THC include
changes in bodily awareness, in motivational drive
and in emotionality, our finding of correlated per-
fusion increases in these two regions suggests in-
creased activity commensurate with the model of
Craig, extending it with the concept of a related
psychotropic effect of THC.
A strong increase in left superior frontal cortex
perfusion following THC is associated with a rela-
tively low rating of feeling high, and vice versa. This
region matches the ‘ lateral rostral prefrontal cortex’
described as being connected to anterior cingulate and
anterior insula (Gilbert et al. 2010). Given the notion
that this network is primarily involved in tasks that
require cognitive control (Bush et al. 2000; Gilbert et al.
2010), our data suggest that the superior frontal cortex
may serve to suppress feeling high. Activity in this
region may then reflect an individual’s abililty to resist
or overcome the sensory and perceptual effects in the
service of maintaining control over one’s mental state.
In literature, subjective measures of intoxication
and of depersonalization due to THC are reportedly
associated with magnitude of CBF increase in frontal
regions (Mathew et al. 1997, 1999). Whether these
disagree with our findings is not clear, because in
those studies subjects rated ‘intoxication’ as opposed
to ‘feeling high’. Intoxication covers a mix of compo-
nents including the feeling of being in a different
mental state, euphoria, anxiety, drowsiness and
changes in bodily awareness. Zuurman et al. (2009)
recently reviewed the literature that assesses acute ef-
fects of cannabis or THC, and indicated that the most
reliable and stable effects that are found after acute
THC or cannabis administration are elevated heart
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rate and subjective effects (i.e. feeling high, stoned or
euphoric). In addition, they differentiate between the
scales ‘high’ and ‘drug effect’, where ‘drug effect’
represents ‘strength of drug effect, feelings of intoxi-
cation, or subjective psychological effects ’. The scales
assessing ‘drug effect’ were not as sensitive as the
scales for ‘high’, and addressed subjective changes
that are less specific for THC or cannabis.
Differences in designs of the studies (e.g. between-
subject comparisons as opposed to within-subject
comparisons in the current study) or in the methods
used (PET vs. ASL) may also contribute to the appar-
ent discrepancy with the present study. In the present
study we corrected for changes in heart rate in the ASL
group analysis and in preprocessing of the resting-
state data. Although in the PET studies corrections are
applied for global CBF, regional effects of heart
rate may not be fully corrected for. The general effect
of THC in the present study (elevated perfusion in
frontal regions) is, however, in line with previous PET
studies (Chang & Chronicle, 2007 ; Martin-Santos et al.
2010; Quickfall & Crockford, 2006). Nevertheless, the
observed alterations in brain neurophysiology during
rest may reflect physical and emotional sensations
(euphoria, feeling high) that form the psychotropic
effects of THC.
One would expect higher CBF to increase resting-
state fluctuations. However, direct comparison be-
tween baseline perfusion measures and resting-state
tSNR showed that CBF may not simply amplify rest-
ing-state fluctuations, as tSNR values were strikingly
similar for THC and placebo in the regions where ASL
showed differences between the two drugs. This is
worth further investigation with direct manipulations
of CBF in a separate study.
THC increased signal fluctuation in the right insula,
substantia nigra, and cerebellum. As these regions also
exhibit high densities of cannabinoid receptors
(Ameri, 1999 ; Iversen, 2003), it is plausible that THC
directly affects neuronal activity by influencing en-
docannabinoid signalling in these regions, rather than
indirectly affecting neuronal activity by changing
neurotransmission through cannabinoid alteration of
dopaminergic or glutamatergic signalling. The elev-
ation of signal fluctuation is then most likely caused by
increased spontaneous activity or by increased ampli-
tude of low frequencies (which dominate our measure
of signal fluctuation). This is supported by the fact that
the cannabinoid system has a neuromodulatory role in
the central nervous system and is capable of mod-
ulating regional synaptic activity (Piomelli, 2003;
Pope et al. 2010). Interestingly, the feeling high effect
of THC is not affected by the dopamine antagonist
haloperidol, supporting the notion of a direct
endocannabinoid basis (D’Souza et al. 2008;
Liem-Moolenaar et al. 2010).
The present study has several limitations. For
one, the effects were not overly strong, so a rather
liberal threshold was used when comparing THC and
placebo in the imaging analyses. It may be that cor-
rection for pre-administration limited sensitivity for
changes. Further, the resting-state fMRI scan was
made during a relatively short period of time (i.e.
4 min), where most studies use at least 8 min of rest
(Damoiseaux et al. 2006; van den Heuvel et al. 2008).
The tight THC administration scheme (van Hell et al.
2011) did not allow for a longer scan between upload
doses. Thus, more regions may be involved in the
psychotropic effects of THC than what is reported
here. The ASL scans did not cover the cerebellum,
perfusion of which is likely to be affected by THC
given the findings in earlier PET studies (Martin-
Santos et al. 2010).
Although the studywasdesigned to be double blind,
THC induced behavioural effects that were identified
by most subjects, possibly causing expectancy effects
across sessions. We tried to minimize the influence of
expectancy by using a randomized cross-over design.
All subjects received THC and placebo on two separate
sessions. By randomizing the order of administration
between subjects (50% of the subjects receive THCfirst,
50% placebo first), expectancy effects were balanced
across sessions. Further, even though most subjects
identified the administered drug correctly, some sub-
jects did not notice onwhich test day they had received
THC. Still, we cannot exclude that expectancy effects
may have affected our results to some extent.
Taken together, our findings indicate that THC in-
creases perfusion and signal fluctuations in anterior
insula. Given the functions attributed to the anterior
insula, we postulate that it plays an important role in
the effects of THC that lead up to feeling high, which
may be related to enhanced interoceptive awareness.
Engagement of the left prefrontal cortex could serve to
suppress this effect. Given the reported role of the
prefrontal cortex in activities that require top-down
control over cognitive processes (Gilbert et al. 2010), it
may well be that engagement of this region enables
one to resist the subjective effects of THC, including
feeling high.
Our findings also indicate usefulness of baseline
measurements in phMRI studies. THC-induced chan-
ges in fMRI brain activity during a cognitive challenge
may not solely be cognitive in nature, as THC exerts
subjective and physiological effects that can interact
with cognitive and emotional brain function. In
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conclusion, the findings raise the possibility that the
primary psychotropic effect of THC, i.e. feeling high,
results from an interplay of regions involved in
subjective interoceptive awareness and in cognitive
control.
Note
Supplementary material accompanies this paper on
the Journal’s website (http://journals.cambridge.org/
pnp).
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